Clinical Utility of FoundationOne Tissue Molecular Profiling in Men with Metastatic Prostate Cancer

PURPOSE: Targeted inhibitors and immunotherapy have entered the treatment landscape of metastatic prostate cancer. Genomic testing may uncover which patients benefit most from these therapies. We report the clinical utility and benefits of FoundationOne testing in men with advanced prostate cancer....

Full description

Saved in:
Bibliographic Details
Published in:Urol Oncol
Main Authors: Zhu, Jason, Tucker, Matthew, Marin, Daniele, Gupta, Rajan T., Healy, Patrick, Humeniuk, Michael, Jarvis, Casey, Zhang, Tian, McNamara, Megan, George, Daniel J., Wu, Yuan, Lisi, Stacey, Armstrong, Andrew J.
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6823135/
https://ncbi.nlm.nih.gov/pubmed/31327751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2019.06.015
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items